L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand binding
- PMID: 10075686
- DOI: 10.1074/jbc.274.12.7913
L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand binding
Abstract
Insulin-sensitizing thiazolidinedione (TZD) compounds are high affinity ligands for a member of the nuclear receptor family, peroxisome proliferator-activated receptor (PPAR) gamma. A scintillation proximity assay for measurement of 3H-radiolabeled TZD binding to human PPARgamma under homogeneous conditions was developed. Using this approach, a novel non-TZD compound (L-764406) was shown to be a potent (apparent binding IC50 of 70 nM) PPARgamma ligand. Preincubation of PPARgamma with L-764406 prevented binding of the [3H]TZD, suggesting a covalent interaction with the receptor; in addition, structurally related analogues of L-764406, which would be predicted not to interact with PPARgamma in a covalent fashion, did not displace [3H]TZD binding to PPARgamma. Covalent binding of L-764406 was proven by an observed molecular weight shift of a tryptic PPARgamma ligand binding domain (LBD) peptide by mass spectrometric analysis. A specific cysteine residue (Cys313 in helix 3 of hPPARgamma2) was identified as the attachment site for this compound. In protease protection experiments, the liganded receptor adopted a typical agonist conformation. L-764406 exhibited partial agonist activity in cells expressing a chimeric receptor containing the PPARgamma LBD and a cognate reporter gene and also induced the expression of the adipocyte-specific gene aP2 in 3T3-L1 cells. In contrast, L-764406 did not exhibit activity in cells transfected with chimeric receptors containing PPARalpha or PPARdelta LBDs. The partial agonist properties of L-764406 were also evident in a co-activator association assay, indicating that the increased transcription in cells was co-activator mediated. Thus, L-764406 is a novel non-TZD ligand for PPARgamma and is also the first known partial agonist for this receptor. The results suggest a critical functional role for Cys313, and helix 3, in contributing to ligand binding and subsequent agonist-induced conformational changes.
Similar articles
-
T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.J Biol Chem. 2002 May 31;277(22):19649-57. doi: 10.1074/jbc.M200743200. Epub 2002 Mar 4. J Biol Chem. 2002. PMID: 11877444
-
Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects.J Biol Chem. 1999 Mar 5;274(10):6718-25. doi: 10.1074/jbc.274.10.6718. J Biol Chem. 1999. PMID: 10037770
-
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.Biochemistry. 2002 May 28;41(21):6640-50. doi: 10.1021/bi0159581. Biochemistry. 2002. PMID: 12022867
-
Toxicological consequences of altered peroxisome proliferator-activated receptor gamma (PPARgamma) expression in the liver: insights from models of obesity and type 2 diabetes.Biochem Pharmacol. 2002 Jan 1;63(1):1-10. doi: 10.1016/s0006-2952(01)00817-6. Biochem Pharmacol. 2002. PMID: 11754868 Review.
-
Insights into Dynamic Mechanism of Ligand Binding to Peroxisome Proliferator-Activated Receptor γ toward Potential Pharmacological Applications.Biol Pharm Bull. 2021;44(9):1185-1195. doi: 10.1248/bpb.b21-00263. Biol Pharm Bull. 2021. PMID: 34471046 Review.
Cited by
-
Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders.PPAR Res. 2008;2008:679137. doi: 10.1155/2008/679137. PPAR Res. 2008. PMID: 18566691 Free PMC article.
-
A novel non-agonist peroxisome proliferator-activated receptor γ (PPARγ) ligand UHC1 blocks PPARγ phosphorylation by cyclin-dependent kinase 5 (CDK5) and improves insulin sensitivity.J Biol Chem. 2014 Sep 19;289(38):26618-26629. doi: 10.1074/jbc.M114.566794. Epub 2014 Aug 6. J Biol Chem. 2014. PMID: 25100724 Free PMC article.
-
Functional interaction between peroxisome proliferator-activated receptors-alpha and Mef-2C on human carnitine palmitoyltransferase 1beta (CPT1beta) gene activation.Nucleic Acids Res. 2004 Sep 8;32(16):4742-9. doi: 10.1093/nar/gkh806. Print 2004. Nucleic Acids Res. 2004. PMID: 15356291 Free PMC article.
-
Selective Modulators of PPAR-gamma Activity: Molecular Aspects Related to Obesity and Side-Effects.PPAR Res. 2007;2007:32696. doi: 10.1155/2007/32696. PPAR Res. 2007. PMID: 17389769 Free PMC article.
-
Differential potencies of naturally occurring regioisomers of nitrolinoleic acid in PPARgamma activation.Biochemistry. 2009 Jan 20;48(2):492-8. doi: 10.1021/bi8016747. Biochemistry. 2009. PMID: 19105608 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials